首页 > 市场调查报告书 > 製药

非专利药生技仿製药

Humira 生物相似药市场，按产品、适应症、按国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测

市场调查报告书

商品编码

1358235

Humira 生物相似药市场，按产品、适应症、按国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测

Humira Biosimilar Market, By Product, By Indication, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

出版日期: 2023年10月01日 | 出版商:

AnalystView Market Insights | 英文 303 Pages | 商品交期: 2-3个工作天内

价格

简介目录图表

报告要点

2022 年 Humira 生物相似药市场规模为 7.901 亿美元，2023 年至 2030 年复合年增长率为 20.9%

Humira 生物相似药市场 - 市场动态：

自体免疫疾病的盛行率不断上升，对生物治疗的需求不断增加
由于修美乐在某些地区的专利到期，修美乐生物相似药市场正在经历显着成长，这使得其他製药公司能够进入该市场并生产更实惠的药物版本。生物相似药为参考药物提供了具有成本效益的替代品，使患者更容易获得治疗并减少医疗支出。此外，自体免疫疾病的盛行率不断上升以及对生物疗法的需求不断增长，也刺激了对 Humira 生物相似药的需求。
由于自体免疫疾病的发生率不断增加以及随后医疗保健支出的激增，在全球范围内，研究和诊断机构正在参与与政府组织合作的倡议。美国国立卫生研究院 (NIH) 的资料显示，自体免疫疾病位列女性死亡率升高的十大原因之一。因此，透过机构和政府机构之间的合作，正在共同努力应对这些健康挑战。

Humira 生物相似药市场 - 主要见解：

根据我们的研究分析师分享的分析，全球 Humira 生物相似药市场预计在预测期内（2023-2030 年）每年将以 20.9% 左右的复合年增长率成长
由于自体免疫疾病盛行率的增加以及对生物治疗的需求不断增加，修美乐生物相似药产业预计将以显着的速度成长
根据适应症类型细分，预计类风湿关节炎将在 2022 年显示最大的市场份额
从产品细分来看，参考生物相似药是2022年的主导类型
按地区划分，北美是 2022 年的主要收入来源

Humira 生物相似药市场-細項分析：

全球 Humira 生物相似药市场根据产品、适应症和地区进行细分。
市场根据产品分为三类：基于参考的生物相似药、具有修饰胺基酸序列的生物相似药和可互换的生物相似药。预计到 2022 年，基于参考的生物相似药领域将主导市场。基于参考的生物相似药是透过直接将其特征和性能与参考药物修美乐（阿达木单抗）进行比较而开发的。它们是使用相似的细胞系和製程製造的，以生产高度相似的产品。
市场依适应症分为四类：类风湿性关节炎、牛皮癣、克隆氏症等。类风湿性关节炎设备部门预计将占收入的最大份额。类风湿性关节炎是一种自体免疫疾病，身体的免疫系统错误地攻击滑膜，滑膜是关节周围的膜内层。这会导致慢性炎症，导致关节损伤、疼痛、肿胀和僵硬。
透过阻断 TNF-α，阿达木单抗有助于减少发炎并减缓关节损伤的进展，从而缓解类风湿性关节炎的症状并改善患者的生活品质。 Humira 生物相似药用于治疗类风湿性关节炎，因为它们含有与参考药物 Humira（阿达木单抗）中的活性成分高度相似的版本。阿达木单抗是一种单株抗体，专门针对和抑制肿瘤坏死因子 α (TNF-α)，这种蛋白质在引起类风湿性关节炎关节发炎方面发挥关键作用。

Humira 生物相似药市场 - 地理洞察：

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲地区。这些区域根据开展业务的国家进一步划分。

Humira 生物相似药市场-竞争格局：

Humira 生物相似药市场的公司正在采取各种策略来获得竞争优势。其中包括投资于广泛的研究和开发，以确保其生物相似药的品质和功效，建立战略伙伴关係或合作以利用互补的专业知识，以及扩大其地理分布以进入新市场。此外，一些公司专注于提供有吸引力的定价模式和出色的售后支持，以吸引更多客户并提高市场份额。

介绍
- 按地理位置分類的细分市场占有率分析
北美洲
- 概述
- Humira 生物相似药北美主要製造商
- 北美市场规模和预测（按国家）
- 北美市场规模和预测（按产品）
- 北美市场规模和预测（按指标）
- 我们
- 加拿大
欧洲
- 概述
- Humira 生物相似药欧洲主要製造商
- 欧洲市场规模和预测（按国家）
- 欧洲市场规模与预测（按产品）
- 欧洲市场规模与预测（按指标）
- 德国
- 义大利
- 英国
- 法国
- 俄罗斯
- 荷兰
- 瑞典
- 波兰
- 欧洲其他地区
亚太地区 (APAC)
- 概述
- Humira 生物相似药亚太地区主要製造商
- 亚太地区市场规模与预测（按国家）
- 亚太地区市场规模与预测（按产品）
- 亚太地区市场规模与预测（依指标）
- 印度
- 中国
- 日本
- 韩国
- 澳洲
- 泰国
- 印尼
- 菲律宾
- 亚太地区其他地区
拉丁美洲
- 概述
- Humira 生物相似药拉丁美洲主要製造商
- 拉丁美洲市场规模与预测（按国家）
- 拉丁美洲市场规模与预测（按产品）
- 拉丁美洲市场规模与预测（按指标）
- 巴西
- 墨西哥
- 阿根廷
- 哥伦比亚
- 拉丁美洲其他地区
中东和非洲
- 概述
- 中东和非洲修美乐生物类似药主要製造商
- 中东和非洲市场规模及预测（按国家）
- 中东和非洲市场规模及预测（按产品）
- 中东和非洲市场规模及预测（依指标）
- 沙乌地阿拉伯
- 阿拉伯聯合大公国
- 以色列
- 土耳其
- 阿尔及利亚
- 埃及
- MEA 的其余部分

第 10 章：主要供应商分析 - Humira 生物相似药产业

竞争仪表板
公司简介
- Amgen
- Samsung Bioepis
- Sandoz (a division of Novartis)
- Mylan (now part of Viatris)
- Boehringer Ingelheim
- Pfizer
- Fresenius Kabi
- Coherus BioSciences
- Merck & Co.

第 11 章：360 度分析师视角

第 12 章：附录

研究方法论
参考
缩写
免责声明
联络我们

简介目录图表

Product Code: ANV1743

REPORT HIGHLIGHT

Humira Biosimilar Market size was valued at USD 790.1 Million in 2022, expanding at a CAGR of 20.9% from 2023 to 2030

Humira biosimilars are biologic drugs that are highly similar to the reference biologic drug Humira (adalimumab). Adalimumab is a monoclonal antibody that targets tumor necrosis factor alpha (TNF-α) and is used to treat various autoimmune diseases, including rheumatoid arthritis, psoriasis, Crohn's disease, and ulcerative colitis. Biosimilars are developed to be comparable in terms of safety, efficacy, and quality to the original drug but are manufactured by different companies after the patent of the reference drug has expired.

Humira Biosimilar Market - Market Dynamics:

Increasing prevalence of autoimmune diseases and the rising demand for biologic treatments

The Humira biosimilar market is experiencing significant growth due to the expiration of Humira's patents in certain regions, allowing other pharmaceutical companies to enter the market and produce more affordable versions of the drug. Biosimilars offer cost-effective alternatives to the reference drug, making treatment more accessible to patients and reducing healthcare expenditures. Additionally, the increasing prevalence of autoimmune diseases and the rising demand for biologic treatments have fueled the demand for Humira biosimilars.

Across the globe, research and diagnostic institutes are engaging in initiatives aligned with government organizations due to the increasing occurrence of autoimmune disorders and the subsequent surge in healthcare spending. The National Institutes of Health (NIH) data reveals that autoimmune disorders rank among the top ten causes of heightened mortality rates in women. As a result, concerted efforts are being made to address these health challenges through collaborative endeavors between institutes and government bodies.

Humira Biosimilar Market - Key Insights:

As per the analysis shared by our research analyst, the global Humira Biosimilar market is estimated to grow annually at a CAGR of around 20.9% over the forecast period (2023-2030)

The Humira Biosimilar industry is projected to grow at a significant rate due to increasing prevalence of autoimmune diseases and the rising demand for biologic treatments

Based on Indication type segmentation, Rheumatoid arthritis was predicted to show maximum market share in the year 2022

Based on Product segmentation, Reference-Based Biosimilars was the leading type in 2022

On the basis of region, North America was the leading revenue generator in 2022

Humira Biosimilar Market- Segmentation Analysis:

The Global Humira Biosimilar Market is segmented on the basis of Product, Indication, and Region.

The market is divided into three categories based on Product: Reference-Based Biosimilars, Biosimilars with Modified Amino Acid Sequences and Interchangeable Biosimilars . In 2022, the Reference-Based Biosimilars segment is projected to dominate the market Reference-Based Biosimilars are developed by directly comparing their characteristics and performance to the reference drug, Humira (adalimumab). They are manufactured using similar cell lines and processes to produce a highly similar product.

The market is divided into four categories based on Indication: Rheumatoid arthritis, psoriasis, Crohn's disease and others. The Rheumatoid arthritis equipment segment is anticipated to hold the largest share in revenue. Rheumatoid arthritis is autoimmune disease in which the body's immune system mistakenly attacks the synovium, which is the lining of the membranes that surround the joints. This results in chronic inflammation, leading to joint damage, pain, swelling, and stiffness.

By blocking TNF-α, adalimumab helps to reduce inflammation and slow down the progression of joint damage, thereby providing relief from the symptoms of rheumatoid arthritis and improving the patient's quality of life. Humira biosimilars are used in the treatment of rheumatoid arthritis because they contain a highly similar version of the active ingredient found in the reference drug Humira (adalimumab). Adalimumab is a monoclonal antibody that specifically targets and inhibits tumor necrosis factor alpha (TNF-α), a protein that plays a key role in causing inflammation in the joints in rheumatoid arthritis.

Humira Biosimilar Market - Geographical Insights:

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Humira Biosimilar Market- Competitive Landscape:

Companies in the Humira biosimilar market are adopting various strategies to gain a competitive edge. These include investing in extensive research and development to ensure the quality and efficacy of their biosimilars, forming strategic partnerships or collaborations to leverage complementary expertise, and expanding their geographic presence to access new markets. Moreover, some companies focus on offering attractive pricing models and excellent after-sales support to attract more customers and enhance their market share.

Recent Developments:

In September 2016, Amjevita (adalimumab-atto) achieved the distinction of being the first FDA-approved biosimilar for Humira. Subsequently, on January 31, 2023, it marked another milestone by becoming the first Humira biosimilar to be launched in the United States. Amjevita is among the approved Humira biosimilars that have received regulatory clearance for treating HS (hidradenitis suppurativa) in adults.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HUMIRA BIOSIMILAR MARKET KEY PLAYERS

Amgen
Samsung Bioepis
Sandoz (a division of Novartis)
Mylan (now part of Viatris)
Boehringer Ingelheim
Pfizer
Fresenius Kabi
Coherus BioSciences
Merck & Co.

GLOBAL HUMIRA BIOSIMILAR MARKET, BY PRODUCT

Reference-Based Biosimilars
Biosimilars with Modified Amino Acid Sequences
Interchangeable Biosimilars

GLOBAL HUMIRA BIOSIMILAR MARKET, BY INDICATION

Rheumatoid arthritis
Psoriasis
Crohn's disease
Others

GLOBAL HUMIRA BIOSIMILAR MARKET, BY REGION

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Humira Biosimilar Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Humira Biosimilar Market Snippet by Product
- 2.1.2. Humira Biosimilar Market Snippet by Indication
- 2.1.3. Humira Biosimilar Market Snippet by Country
- 2.1.4. Humira Biosimilar Market Snippet by Region
2.2. Competitive Insights

3. Humira Biosimilar Key Market Trends

3.1. Humira Biosimilar Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Humira Biosimilar Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Humira Biosimilar Market Opportunities
3.4. Humira Biosimilar Market Future Trends

4. Humira Biosimilar Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Humira Biosimilar Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Humira Biosimilar Market Landscape

6.1. Humira Biosimilar Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Humira Biosimilar Market - By Product

7.1. Overview
- 7.1.1. Segment Share Analysis, By Product, 2022 & 2030 (%)
- 7.1.2. Reference-Based Biosimilars
- 7.1.3. Biosimilars with Modified Amino Acid Sequences
- 7.1.4. Interchangeable Biosimilars

8. Humira Biosimilar Market - By Indication

8.1. Overview
- 8.1.1. Segment Share Analysis, By Indication, 2022 & 2030 (%)
- 8.1.2. Rheumatoid arthritis
- 8.1.3. Psoriasis
- 8.1.4. Crohn's disease
- 8.1.5. Others

9. Humira Biosimilar Market- By Geography

9.1. Introduction
- 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
9.2. North America
- 9.2.1. Overview
- 9.2.2. Humira Biosimilar Key Manufacturers in North America
- 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.2.4. North America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 9.2.5. North America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.2.6. U.S.
  - 9.2.6.1. Overview
  - 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.2.6.3. U.S. Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.2.6.4. U.S. Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.2.7. Canada
  - 9.2.7.1. Overview
  - 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.2.7.3. Canada Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.2.7.4. Canada Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.3. Europe
- 9.3.1. Overview
- 9.3.2. Humira Biosimilar Key Manufacturers in Europe
- 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.3.4. Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 9.3.5. Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.3.6. Germany
  - 9.3.6.1. Overview
  - 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.3.6.3. Germany Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.3.6.4. Germany Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.3.7. Italy
  - 9.3.7.1. Overview
  - 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.3.7.3. Italy Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.3.7.4. Italy Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.3.8. United Kingdom
  - 9.3.8.1. Overview
  - 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.3.8.3. United Kingdom Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.3.8.4. United Kingdom Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.3.9. France
  - 9.3.9.1. Overview
  - 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.3.9.3. France Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.3.9.4. France Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.3.10. Russia
  - 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.3.10.2. Russia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.3.10.3. Russia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.3.11. Netherlands
  - 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.3.11.2. Netherlands Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.3.11.3. Netherlands Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.3.12. Sweden
  - 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.3.12.2. Sweden Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.3.12.3. Sweden Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.3.13. Poland
  - 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.3.13.2. Poland Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.3.13.3. Poland Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.3.14. Rest of Europe
  - 9.3.14.1. Overview
  - 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.3.14.3. Rest of the Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.3.14.4. Rest of the Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.4. Asia Pacific (APAC)
- 9.4.1. Overview
- 9.4.2. Humira Biosimilar Key Manufacturers in Asia Pacific
- 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.4.4. Asia Pacific Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 9.4.5. Asia Pacific Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.4.6. India
  - 9.4.6.1. Overview
  - 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.4.6.3. India Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.4.6.4. India Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.4.7. China
  - 9.4.7.1. Overview
  - 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.4.7.3. China Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.4.7.4. China Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.4.8. Japan
  - 9.4.8.1. Overview
  - 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.4.8.3. Japan Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.4.8.4. Japan Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.4.9. South Korea
  - 9.4.9.1. Overview
  - 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.4.9.3. South Korea Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.4.9.4. South Korea Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.4.10. Australia
  - 9.4.10.1. Overview
  - 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.4.10.3. Australia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.4.10.4. Australia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.4.11. Thailand
  - 9.4.11.1. Overview
  - 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.4.11.3. Thailand Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.4.11.4. Thailand Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.4.12. Indonesia
  - 9.4.12.1. Overview
  - 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.4.12.3. Indonesia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.4.12.4. Indonesia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.4.13. Philippines
  - 9.4.13.1. Overview
  - 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.4.13.3. Philippines Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.4.13.4. Philippines Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.4.14. Rest of APAC
  - 9.4.14.1. Overview
  - 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.4.14.3. Rest of APAC Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.4.14.4. Rest of APAC Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.5. Latin America
- 9.5.1. Overview
- 9.5.2. Humira Biosimilar Key Manufacturers in Latin America
- 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.5.4. Latin America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 9.5.5. Latin America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.5.6. Brazil
  - 9.5.6.1. Overview
  - 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.5.6.3. Brazil Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.5.6.4. Brazil Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.5.7. Mexico
  - 9.5.7.1. Overview
  - 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.5.7.3. Mexico Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.5.7.4. Mexico Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.5.8. Argentina
  - 9.5.8.1. Overview
  - 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.5.8.3. Argentina Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.5.8.4. Argentina Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.5.9. Colombia
  - 9.5.9.1. Overview
  - 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.5.9.3. Colombia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.5.9.4. Colombia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.5.10. Rest of LATAM
  - 9.5.10.1. Overview
  - 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.5.10.3. Rest of LATAM Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.5.10.4. Rest of LATAM Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.6. Middle East and Africa
- 9.6.1. Overview
- 9.6.2. Humira Biosimilar Key Manufacturers in Middle East and Africa
- 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.6.4. Middle East and Africa Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 9.6.5. Middle East and Africa Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.6.6. Saudi Arabia
  - 9.6.6.1. Overview
  - 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.6.6.3. Saudi Arabia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.6.6.4. Saudi Arabia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.6.7. United Arab Emirates
  - 9.6.7.1. Overview
  - 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.6.7.3. United Arab Emirates Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.6.7.4. United Arab Emirates Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.6.8. Israel
  - 9.6.8.1. Overview
  - 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.6.8.3. Israel Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.6.8.4. Israel Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.6.9. Turkey
  - 9.6.9.1. Overview
  - 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.6.9.3. Turkey Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.6.9.4. Turkey Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.6.10. Algeria
  - 9.6.10.1. Overview
  - 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.6.10.3. Algeria Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.6.10.4. Algeria Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.6.11. Egypt
  - 9.6.11.1. Overview
  - 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.6.11.3. Egypt Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.6.11.4. Egypt Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.6.12. Rest of MEA
  - 9.6.12.1. Overview
  - 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.6.12.3. Rest of MEA Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.6.12.4. Rest of MEA Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- Humira Biosimilar Industry

10.1. Competitive Dashboard
10.2. Company Profiles
- 10.2.1. Amgen
- 10.2.2. Samsung Bioepis
- 10.2.3. Sandoz (a division of Novartis)
- 10.2.4. Mylan (now part of Viatris)
- 10.2.5. Boehringer Ingelheim
- 10.2.6. Pfizer
- 10.2.7. Fresenius Kabi
- 10.2.8. Coherus BioSciences
- 10.2.9. Merck & Co.

11. 360 Degree Analyst View

12. Appendix

12.1. Research Methodology
12.2. References
12.3. Abbreviations
12.4. Disclaimer
12.5. Contact Us

简介目录图表

List of Tables

TABLE List of data sources
TABLE Market drivers; Impact Analysis
TABLE Market restraints; Impact Analysis
TABLE Humira Biosimilar Market: Product Snapshot (2022)
TABLE Segment Dashboard; Definition and Scope, by Product
TABLE Global Humira Biosimilar Market, by Product 2018-2030 (USD Million)
TABLE Humira Biosimilar Market: Indication Snapshot (2022)
TABLE Segment Dashboard; Definition and Scope, by Indication
TABLE Global Humira Biosimilar Market, by Indication 2018-2030 (USD Million)
TABLE Humira Biosimilar Market: Regional snapshot (2022)
TABLE Segment Dashboard; Definition and Scope, by Region
TABLE Global Humira Biosimilar Market, by Region 2018-2030 (USD Million)
TABLE North America Humira Biosimilar Market, by Country, 2018-2030 (USD Million)
TABLE North America Humira Biosimilar Market, by Product, 2018-2030 (USD Million)
TABLE North America Humira Biosimilar Market, by Indication, 2018-2030 (USD Million)
TABLE Europe Humira Biosimilar Market, by Country, 2018-2030 (USD Million)
TABLE Europe Humira Biosimilar Market, by Product, 2018-2030 (USD Million)
TABLE Europe Humira Biosimilar Market, by Indication, 2018-2030 (USD Million)
TABLE Asia Pacific Humira Biosimilar Market, by Country, 2018-2030 (USD Million)
TABLE Asia Pacific Humira Biosimilar Market, by Product, 2018-2030 (USD Million)
TABLE Asia Pacific Humira Biosimilar Market, by Indication, 2018-2030 (USD Million)
TABLE Latin America Humira Biosimilar Market, by Country, 2018-2030 (USD Million)
TABLE Latin America Humira Biosimilar Market, by Product, 2018-2030 (USD Million)
TABLE Latin America Humira Biosimilar Market, by Indication, 2018-2030 (USD Million)
TABLE Middle East and Africa Humira Biosimilar Market, by Country, 2018-2030 (USD Million)
TABLE Middle East and Africa Humira Biosimilar Market, by Product, 2018-2030 (USD Million)
TABLE Middle East and Africa Humira Biosimilar Market, by Indication, 2018-2030 (USD Million)

List of Figures

FIGURE Humira Biosimilar Market Segmentation
FIGURE Market research methodology
FIGURE Value chain analysis
FIGURE Porter's Five Forces Analysis
FIGURE Market Attractiveness Analysis
FIGURE COVID-19 Impact Analysis
FIGURE Pre & Post COVID-19 Impact Comparision Study
FIGURE Competitive Landscape; Key company market share analysis, 2022
FIGURE Product segment market share analysis, 2022 & 2030
FIGURE Product segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Indication segment market share analysis, 2022 & 2030
FIGURE Indication segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Regional segment market share analysis, 2022 & 2030
FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE North America Humira Biosimilar Market share and leading players, 2022
FIGURE Europe Humira Biosimilar Market share and leading players, 2022
FIGURE Asia Pacific Humira Biosimilar Market share and leading players, 2022
FIGURE Latin America Humira Biosimilar Market share and leading players, 2022
FIGURE Middle East and Africa Humira Biosimilar Market share and leading players, 2022
FIGURE North America market share analysis by country, 2022
FIGURE U.S. Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Canada Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Europe Humira Biosimilar Market share analysis by country, 2022
FIGURE Germany Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Spain Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Italy Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE France Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE UK Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Russia Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Netherlands Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Sweden Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Poland Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Rest of the Europe Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Asia Pacific Humira Biosimilar Market share analysis by country, 2022
FIGURE India Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE China Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Japan Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE South Korea Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Australia Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Thailand Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Indonesia Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Phillipines Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Rest of APAC Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Latin America Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Latin America Humira Biosimilar Market share analysis by country, 2022
FIGURE Brazil Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Mexico Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Argentina Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Colombia Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Rest of LATAM Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Middle East and Africa Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Middle East and Africa Humira Biosimilar Market share analysis by country, 2022
FIGURE Saudi Arabia Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE United Arab Emirates Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Israel Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Turkey Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Algeria Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Egypt Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Rest of MEA Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)